Sonographic detection of perihepatic lymphadenopathy is an indicator for primary sclerosing cholangitis in patients with inflammatory bowel disease

International Journal of Colorectal Disease

Volumn 19, Issue 6, 2004, Pages 586-594

  Hirche, Tim O ^a   Russler, Jan ^a   Braden, Barbara ^a   Schuessler, Gudrun ^b   Zeuzem, Stefan ^a   Wehrmann, Till ^a   Seifert, Hans ^c   Dietrich, Christoph F ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b CARITAS KRANKENHAUS   (Germany)

^c KLINIKUM OLDENBURG   (Germany)

Author keywords

Inflammatory bowel disease; Lymphadenopathy; Primary sclerosing cholangitis; Ultrasound

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTERITIS; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; PATIENT SELECTION; PREDICTION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; VIRUS HEPATITIS;

ADOLESCENT; ADULT; AGED; CHOLANGITIS, SCLEROSING; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; LYMPHATIC DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 7444264723     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-004-0598-0     Document Type: Article

References (45)

1. Hanauer SB, Present DH (2003) The state of the art in the management of inflammatory bowel disease. Rev Gastroenterol Disord 3:81-92
2. Raj V, Lichtenstein DR (1999) Hepatobiliary manifestations of inflammatory bowel disease. Gastroenterol Clin North Am 28:491-513
3. Broome U, Glaumann H, Hellers G, Nilsson B, Sorstad J, Hultcrantz R (1994) Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm. Gut 35:84-89
4. Purrmann J, Modder U, Cleveland S, Seibold F, Burchard A, Gemsa R, Lubke H (1993) Association of primary sclerosing cholangitis with inflammatory bowel diseases: a prospective study. Z Gastroenterol 31[Suppl 5]:56-59
5. Aadland E, Schrumpf E, Fausa O, Elgjo K, Heilo A, Aakhus T, Gjone E (1987) Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol 22:655-664
6. Stockbrugger RW, Olsson R, Jaup B, Jensen J (1988) Forty-six patients with primary sclerosing cholangitis: radiological bile duct changes in relationship to clinical course and concomitant inflammatory bowel disease. Hepatogastroenterology 35:289-294
7. Riegler G, D'Inca R, Sturniolo GC, Corrao G, Del Vecchio BC, Di L, V, Carratu R, Ingrosso M, Pelli MA, Morini S, Valpiani D, Cantarini D, Usai P, Papi C, Caprilli R (1998) Hepatobiliary alterations in patients with inflammatory bowel disease: a multicenter study. Caprilli & Gruppo Italiano Studio Colon-Retto. Scand J Gastroenterol 33:93-98
8. Schrumpf E, Fausa O, Elgjo K, Kolmannskog F (1988) Hepatobiliary complications of inflammatory bowel disease. Semin Liver Dis 8:201-209
9. Fausa O, Schrumpf E, Elgjo K (1991) Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 11:31-39
10. Schrumpf E, Elgjo K, Fausa O, Gjone E, Kolmannskog F, Ritland S (1980) Sclerosing cholangitis in ulcerative colitis. Scand J Gastroenterol 15:689-697
11. Varghese JC, Farrell MA, Courtney G, Osborne H, Murray FE, Lee MJ (1999) Role of MR cholangiopancreatography in patients with failed or inadequate ERCP. AJR Am J Roentgenol 173:1527-1533
12. Wojtun S, Gil M, Gil J (2000) Recognition of ERC-induced pancreatitis in patients with choledocholithiasis by an analysis of laboratory findings. Hepatogastroenterology 47:550-553
13. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, De Bernardin M, Ederle A, Fina P, Fratton A (1998) Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 48:1-10
14. Majoie CB, Smits NJ, Phoa SS, Reeders JW, Jansen PL (1995) Primary sclerosing cholangitis: sonographic findings. Abdom Imaging 20:109-112
15. Oikarinen H, Paakko E, Suramo I, Paivansalo M, Tervonen O, Lehtola J, Aukee J (2001) Imaging and estimation of the prognostic features of primary sclerosing cholangitis by ultrasonography and MR cholangiography. Acta Radiol 42:403-408
16. Dietrich CF, Stryjek-Kaminska D, Teuber G, Lee JH, Caspary WF, Zeuzem S (2000) Perihepatic lymph nodes as a marker of antiviral response in patients with chronic hepatitis C infection. AJR Am J Roentgenol 174:699-704
17. Dietrich CF, Leuschner MS, Zeuzem S, Herrmann G, Sarrazin C, Caspary WF, Leuschner UF (1999) Peri-hepatic lymphadenopathy in primary biliary cirrhosis reflects progression of the disease. Eur J Gastroenterol Hepatol 11:747-753
18. Dietrich CF, Gottschalk R, Herrmann G, Caspary WF, Zeuzem S (1997) Sonographic detection of lymph nodes in the hepatoduodenal ligament. Dtsch Med Wochenschr 122:1269-1274
19. Johnson KJ, Olliff JF, Olliff SP (1998) The presence and significance of lymphadenopathy detected by CT in primary sclerosing cholangitis. Br J Radiol 71:1279-1282
20. Dietrich CF, Zeuzem S (1999) Sonographic detection of perihepatic lymph nodes: technique and clinical value. Z Gastroenterol 37:141-151
21. Dietrich CF, Zeuzem S, Caspary WF, Wehrmann T (1998) Ultrasound lymph node imaging in the abdomen and retroperitoneum of healthy probands. Ultraschall Med 19:265-269
22. Dietrich CF, Lee JH, Herrmann G, Teuber G, Roth WK, Caspary WF, Zeuzem S (1997) Enlargement of perihepatic lymph nodes in relation to liver histology and viremia in patients with chronic hepatitis C. Hepatology 26:467-472; Erratum (1998) 28:1444
23. Gottschalk R, Wigand R, Dietrich CF, Oremek G, Liebisch F, Hoelzer D, Kaltwasser JP (2000) Total iron-binding capacity and serum transferrin determination under the influence of several clinical conditions. Clin Chim Acta 293:127-138
24. Hirche H, Joeckel KH (2000) Advice for the statistical evaluation of means and percentages by confidence interval analysis. In: Ruebben H (ed) Uroonkologie. Springer, Berlin Heidelberg New York, pp 909-915
25. Rosner B (2000) Fundamentals of biostatistics, 5th edn. Thomson, Hamshire
26. Feinstein AR (1975) Clinical biostatistics XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests. Clin Pharmacol Ther 17:104-116
27. Broome U, Olsson R, Loof L, Bodemar G, Hultcrantz R, Danielsson A, Prytz H, Sandberg-Gertzen H, Wallerstedt S, Lindberg G (1996) Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 38:610-615
28. Ponsioen CI, Tytgat GN (1998) Primary sclerosing cholangitis: a clinical review. Am J Gastroenterol 93:515-523
29. Wiesner RH, Grambsch PM, Dickson ER, Ludwig J, MacCarty RL, Hunter EB, Fleming TR, Fisher LD, Beaver SJ, LaRusso NF (1989) Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 10:430-436
30. Loftus EV Jr, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton LJ III (1996) Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 110:432-440
31. Angulo P, Lindor KD (1999) Primary sclerosing cholangitis. Hepatology 30:325-332
32. van den Hazel SJ, Wolfhagen EH, van Buuren HR, van de Meeberg PC, Van Leeuwen DJ (2000) Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis. Dutch PSC Study Group. Endoscopy 32:779-782
33. Trap R, Adamsen S, Hart-Hansen O, Henriksen M (1999) Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals. Endoscopy 31:125-130
34. Johnson GK, Geenen JE, Johanson JF, Sherman S, Hogan WJ, Cass O (1997) Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Mid-west Pancreaticobiliary Study Group. Gastrointest Endosc 46:217-222
35. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL (1984) Current concepts. Primary sclerosing cholangitis. N Engl J Med 310:899-903
36. Balasubramaniam K, Wiesner RH, LaRusso NF (1988) Primary sclerosing cholangitis with normal serum alkaline phosphatase activity. Gastroenterology 95:1395-1398
37. Outwater E, Kaplan MM, Bankoff MS (1992) Lymphadenopathy in sclerosing cholangitis: pitfall in the diagnosis of malignant biliary obstruction. Gastrointest Radiol 17:157-160
38. Warren KW, Athanassiades S, Monge JI (1966) Primary sclerosing cholangitis. A study of forty-two cases. Am J Surg 111:23-38
39. Dodd GD III, Baron RL, Oliver JH III, Federle MP (1999) End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients. Radiology 211:357-362
40. Ito K, Mitchell DG, Outwater EK, Blasbalg R (1999) Primary sclerosing cholangitis: MR imaging features. AJR Am J Roentgenol 172:1527-1533
41. Hubscher SG, Harrison RF (1989) Portal lymphadenopathy associated with lipofuscin in chronic cholestatic liver disease. J Clin Pathol 42:1160-1165
42. Bass NM, Chapman RW, O'Reilly A, Sherlock S (1983) Sclerosing cholangitis asociated with angioimmunoblastic lymphadenopathy. Gastroenterol 85:420-424
43. Thompson HH, Pitt HA, Lewin KJ, Longmire WP Jr (1984) Sclerosing cholangitis and histiocytosis X. Gut 25:526-530
44. Dodd GD III, Baron RL, Oliver JH III, Federle MP, Baumgartel PB (1997) Enlarged abdominal lymph nodes in end-stage cirrhosis: CT-histopathologic correlation in 507 patients. Radiology 203:127-130
45. Rabinovitz M, Gavaler JS, Schade RR, Dindzans VJ, Chien MC, Van Thiel DH (1990) Does primary sclerosing cholangitis occuring in association with inflammatory bowel disease differ from that occuring in the absence of inflammatory bowel disease? A study of sixty-six subjects. Hepatology 11:7-11.